Evidence map›Paper›PMID 40442701›Full record

ArticleMolecular cytogenetics2025

Optical genome mapping enhances cytogenetic analysis in recurrent miscarriage: confirmation of a suspected (1;10) chromosomal translocation.

María Del Mar Del Águila, Mónica Bernal, José Ramón Vílchez, Bárbara Romero, José Antonio Castilla, Gemma Álvarez, Ana Clavero, Antonio Poyatos, Francisco Ruíz-Cabello

Abstract read
In one paragraph

Article in Molecular cytogenetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

María Del Mar Del ÁguilaServicio de Análisis Clínicos, Inmunología y Reproducción Humana Asistida, Hospital Universitario Virgen de Las Nieves, Granada, Spain. mariam.aguila.sspa@juntadeandalucia.es.
Mónica BernalServicio de Análisis Clínicos, Inmunología y Reproducción Humana Asistida, Hospital Universitario Virgen de Las Nieves, Granada, Spain.
José Ramón VílchezServicio de Análisis Clínicos, Inmunología y Reproducción Humana Asistida, Hospital Universitario Virgen de Las Nieves, Granada, Spain.
Bárbara RomeroServicio de Ginecología y Obstetricia, Unidad de Reproducción Humana Asistida, Hospital Universitario Virgen de Las Nieves, Granada, Spain.
José Antonio CastillaInstituto de Investigación Biosanitaria Ibs.GRANADA, Granada, Spain.
Gemma ÁlvarezServicio de Análisis Clínicos, Inmunología y Reproducción Humana Asistida, Hospital Universitario Virgen de Las Nieves, Granada, Spain.
Ana ClaveroServicio de Análisis Clínicos, Inmunología y Reproducción Humana Asistida, Hospital Universitario Virgen de Las Nieves, Granada, Spain.
Antonio PoyatosServicio de Análisis Clínicos, Inmunología y Reproducción Humana Asistida, Hospital Universitario Virgen de Las Nieves, Granada, Spain.
Francisco Ruíz-CabelloServicio de Análisis Clínicos, Inmunología y Reproducción Humana Asistida, Hospital Universitario Virgen de Las Nieves, Granada, Spain.

Funding

FEDER funds (B-CTS-410--UGR-20) and (Group CTS-143)
6 · The paper itself

Abstract

backgroundOptical genome mapping (OGM) is a next-generation cytogenetic technique that may be beneficial for detecting subtle structural chromosomal alterations that can go unnoticed with conventional studies in couples with recurrent pregnancy loss. CASE PRESENTATION: We report the case of a couple referred to our assisted reproduction unit due to a history of recurrent pregnancy loss. Initially, conventional cytogenetic studies were performed to identify a possible genetic cause. To this end, the karyotypes of both members of the couple were determined. The fetal tissue from the third miscarriage was analyzed using comparative genome hybridization (CGH) array. Subsequently, the cytogenetic analysis of the couple was extended with the OGM technique. Basic infertility studies revealed normal results, and the karyotypes of both partners were initially reported as normal with respect to structural abnormalities. Following the third miscarriage, an array CGH analysis of the abortive tissue detected a deletion-duplication on chromosomes 1 and 10, respectively. Moreover, OGM revealed a balanced translocation between chromosomes 1 and 10 in the male which had not been detected through conventional karyotyping. A retrospective review of the karyotype by an expert cytogeneticist identified an apparent translocation that had previously gone unrecognized.

conclusionsStructural chromosomal abnormalities may be underestimated in couples experiencing multiple miscarriages because they are not always accurately recognized by conventional cytogenetic techniques. OGM offers a valuable complement to these traditional methods by identifying chromosomal alterations that may have been overlooked by karyotyping, precisely characterizing the nature of the structural rearrangements. While OGM cannot currently replace karyotyping due to limitations such as the inability to detect certain translocations (e.g., Robertsonian translocations), it can enhance diagnostic accuracy and provide additional insights into the genetic causes of repeated pregnancy loss. Therefore, OGM may serve as a useful supplementary tool for improving diagnosis and management in affected couples.

Indexed as

Apparent chromosome translocationBalanced translocationsOptical genome mappingPreimplantation genetic testingRecurrent pregnancy loss

Identifiers

PMID40442701
PMCPMC12123785

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.